source
- FDA approves 23 new drugs in first half, marking best pace in three years despite staff cutsThe FDA announced that it has approved 23 novel drugs during the first half of 2026, the strongest approval count in three years. The approvals come after the Trump administration reduced FDA staf…
- Novartis to buy Myricx Bio for up to $1.5 billion, adding two novel ADCs to its oncology portfolioNovartis announced it will acquire Myricx Bio, a UK‑based biotech that develops antibody drug conjugates (ADCs), in a move to broaden its oncology pipeline. The transaction is valued at up to $1.5…